Biglycan Involvement in Heart Fibrosis: Modulation of Adenosine 2A Receptor Improves Damage in Immortalized Cardiac Fibroblasts

Biglycan Involvement in Heart Fibrosis: Modulation of Adenosine 2A Receptor Improves Damage in Immortalized Cardiac Fibroblasts

Cardiac fibrosis is a common pathological feature of different cardiovascular diseases, characterized by the aberrant deposition of extracellular matrix (ECM) proteins in the cardiac interstitium, myofibroblast differentiation and increased fibrillar collagen deposition stimulated by transforming gr...

Full description

Bibliographic Details
Main Authors:	Michele Scuruchi, Federica Mannino, Chiara Imbesi, Giovanni Pallio, Giovanna Vermiglio, Gianluca Bagnato, Letteria Minutoli, Alessandra Bitto, Francesco Squadrito, Natasha Irrera
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	International Journal of Molecular Sciences
Subjects:	cardiac fibrosis A<sub>2A</sub> receptor biglycan collagen
Online Access:	https://www.mdpi.com/1422-0067/24/2/1784

Similar Items

Targeting Adenosine Receptor by Polydeoxyribonucleotide: An Effective Therapeutic Strategy to Induce White-to-Brown Adipose Differentiation and to Curb Obesity
by: Federica Mannino, et al.
Published: (2021-07-01)

Breast cancer dataset with biomarker Biglycan
by: Pedro Clarindo da Silva Neto, et al.
Published: (2023-04-01)

Biglycan regulates bone development and regeneration
by: Reut Shainer, et al.
Published: (2023-02-01)

Decorin knockdown is beneficial for aged tendons in the presence of biglycan expression
by: Zakary M. Beach, et al.
Published: (2022-08-01)

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
by: Christoforos K. Vaxevanis, et al.
Published: (2023-12-01)

NLRP3 Inflammasome: A New Pharmacological Target for Reducing Testicular Damage Associated with Varicocele
by: Pietro Antonuccio, et al.
Published: (2021-01-01)

Correction: Mannino et al. Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells. <em>Cancers</em> 2021, <em>13</em>, 5741
by: Federica Mannino, et al.
Published: (2023-11-01)

Identification, characterization and expression analysis of biglycan in asian elephant (elephas maximus)
by: Siriwadee CHOMDEJ, et al.
Published: (2017-09-01)

Biglycan and reduced glycolysis are associated with breast cancer cell dormancy in the brain
by: Ashley Sunderland, et al.
Published: (2023-06-01)

The Proteoglycan Biglycan Modulates Platelet Adhesion and Thrombus Formation in a GPVI-Dependent Manner
by: Henrike Hoermann, et al.
Published: (2021-11-01)

Aberrant expression of the extracellular matrix component Biglycan regulated by Hedgehog signalling promotes colorectal cancer cell proliferation
by: Zeng Shaopeng, et al.
Published: (2021-12-01)

Roles of Two Small Leucine-Rich Proteoglycans Decorin and Biglycan in Pregnancy and Pregnancy-Associated Diseases
by: Chidambra D. Halari, et al.
Published: (2021-09-01)

Corrigendum: Pharmacological activity and clinical use of PDRN
by: Francesco Squadrito, et al.
Published: (2022-11-01)

Pharmacology of Adenosine Receptors: Recent Advancements
by: Fabrizio Vincenzi, et al.
Published: (2023-09-01)

Extracellular Matrix Proteomics: The <i>mdx-4cv</i> Mouse Diaphragm as a Surrogate for Studying Myofibrosis in Dystrophinopathy
by: Paul Dowling, et al.
Published: (2023-07-01)

Corrigendum: Adenosine receptor stimulation by polydeoxyribonucleotide improves tissue repair and symptomology in experimental colitis
by: Giovanni Pallio, et al.
Published: (2022-11-01)

Opposing Effects of Adenosine and Inosine in Human Subcutaneous Fibroblasts May Be Regulated by Third Party ADA Cell Providers
by: Carina Herman-de-Sousa, et al.
Published: (2020-03-01)

The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness
by: Filipe Pinto, et al.
Published: (2021-03-01)

MAO-A Inhibition by Metaxalone Reverts IL-1β-Induced Inflammatory Phenotype in Microglial Cells
by: Giovanni Pallio, et al.
Published: (2021-08-01)

Salivary biglycan-neo-epitope-BGN262: A novel surrogate biomarker for equine osteoarthritic sub-chondral bone sclerosis and to monitor the effect of short-term training and surface arena
by: S. Adepu, et al.
Published: (2023-06-01)

The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican
by: Aikaterini Berdiaki, et al.
Published: (2023-07-01)

Anti-oxidant and anti-inflammatory effects of ellagic and punicic acid in an in vitro model of cardiac fibrosis
by: Federica Mannino, et al.
Published: (2023-06-01)

A Necessary Role for Increased Biglycan Expression during L1-Mediated Colon Cancer Progression
by: Arka Saha, et al.
Published: (2021-12-01)

IGF-1 Upregulates Biglycan and Decorin by Increasing Translation and Reducing ADAMTS5 Expression
by: Hanon Lee, et al.
Published: (2021-01-01)

Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy
by: Eirini-Maria Giatagana, et al.
Published: (2022-02-01)

The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury
by: Natasha Irrera, et al.
Published: (2020-08-01)

Corrigendum: Activation of A2A receptor by PDRN reduces neuronal damage and stimulates WNT/β-catenin driven neurogenesis in spinal cord injury
by: Natasha Irrera, et al.
Published: (2022-11-01)

Prediction of Preterm Delivery Using Serum Ischemia Modified Albumin, Biglycan, and Decorin Levels in Women with Threatened Preterm Labor
by: Ismail Biyik, et al.
Published: (2024-01-01)

Biglycan Promotes Cancer Stem Cell Properties, NFκB Signaling and Metastatic Potential in Breast Cancer Cells
by: Kanakaraju Manupati, et al.
Published: (2022-01-01)

Adenosine A<sub>2A</sub> Receptors Shut Down Adenosine A<sub>1</sub> Receptor-Mediated Presynaptic Inhibition to Promote Implementation of Hippocampal Long-Term Potentiation
by: Cátia R. Lopes, et al.
Published: (2023-04-01)

Beta-Caryophyllene, a Plant-Derived CB2 Receptor Agonist, Protects SH-SY5Y Cells from Cadmium-Induced Toxicity
by: Federica Mannino, et al.
Published: (2023-10-01)

Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells
by: Federica Mannino, et al.
Published: (2021-11-01)

How Are Adenosine and Adenosine A<sub>2A</sub> Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
by: Akihisa Mori, et al.
Published: (2021-08-01)

Combined Treatment with Polynucleotides and Hyaluronic Acid Improves Tissue Repair in Experimental Colitis
by: Giovanni Pallio, et al.
Published: (2020-10-01)

Atherosclerosis Plaque Reduction by Lycopene Is Mediated by Increased Energy Expenditure through AMPK and PPARα in ApoE KO Mice Fed with a High Fat Diet
by: Federica Mannino, et al.
Published: (2022-07-01)

RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Motility in Human Pancreatic Cancer
by: Hendrik Ungefroren, et al.
Published: (2024-01-01)

Pathophysiological Role and Medicinal Chemistry of A<sub>2A</sub> Adenosine Receptor Antagonists in Alzheimer’s Disease
by: Stefania Merighi, et al.
Published: (2022-04-01)

New Insights into Key Determinants for Adenosine 1 Receptor Antagonists Selectivity Using Supervised Molecular Dynamics Simulations
by: Giovanni Bolcato, et al.
Published: (2020-05-01)

Antiplatelet Effects of Selected Xanthine-Based Adenosine A<sub>2A</sub> and A<sub>2B</sub> Receptor Antagonists Determined in Rat Blood
by: Monika Kubacka, et al.
Published: (2023-08-01)

Guanosine-Mediated Anxiolytic-Like Effect: Interplay with Adenosine A<sub>1</sub> and A<sub>2A</sub> Receptors
by: Monica Frinchi, et al.
Published: (2020-12-01)